1 / 7

Global Oncology Biosimilars Market 2014-2018

Big Market Research has announced a new Report Package "Global Oncology Biosimilars Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential"<br><br>Get Complete Details At: http://www.bigmarketresearch.com/global-oncology-biosimilars-2014-2018-market<br><br>Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopharmaceutical product.<br><br>Enquire At: http://www.bigmarketresearch.com/report-enquiry/169979

yvar_everts
Download Presentation

Global Oncology Biosimilars Market 2014-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Oncology Biosimilars Market 2014-2018 Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2018 Published Date: Nov2014

  2. Report Description About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopharmaceutical product. Currently, biosimilars are being incorporated into oncology treatment practices. The biosimilars used in oncology in the supportive care setting are known as oncology biosimilars. The Global Oncology Biosimilars market to grow at a CAGR of 29.87 percent over the period 2013-2018. Get Complete Report At: http://www.bigmarketresearch.com/global-oncology-biosimilars-2014-2018-market Covered in this Report This report covers the present scenario and the growth prospects of the Global Oncology Biosimilars market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales biosimilars used in cancer treatment. Global Oncology Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

  3. Report Description The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Oncology Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA Enquire About This Report At: http://www.bigmarketresearch.com/report-enquiry/169979 Key Vendors • Biocon • Celltrion • Dr. Reddy's Laboratories • Hospira • Mylan • Sandoz

  4. Report Description Other Prominent Vendors • 3SBio • Abbvie • AstraZeneca • BioXpress Therapeutics • BoehringerIngelheim • Coherus Biosciences • Intas Pharmaceuticals • Merck Serono • Pfizer • Wockhardt Market Driver • Increased Number of Patent Expirations • For a full, detailed list, view our report Market Challenge • Risks Related to Drug Failure • For a full, detailed list, view our report

  5. Report Description Market Trend • Outsourcing of Biosimilar Manufacturing • For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?

  6. Table Of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Segmentation by Application 08. Market Segmentation by Drug Class 09. Geographical Segmentation 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape Get Complete TOC At: http://www.bigmarketresearch.com/global-oncology-biosimilars-2014-2018-market

  7. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/global-oncology-biosimilars-2014-2018-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related